Optimized RPE65 promoter and coding sequences
US10568973B2 · kind B2 · utility
1Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2016 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Feb 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the prevention and/or treatment of retinal dystrophyin a patient, including Leber congenital amaurosis (LCA).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.